Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study. [electronic resource]
Producer: 20150723Description: 6838-46 p. digitalISSN:- 1873-2518
- Adolescent
- Adult
- Antibodies, Bacterial -- blood
- Bacterial Proteins -- immunology
- Double-Blind Method
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Healthy Volunteers
- Humans
- Hydrolases -- immunology
- Male
- Placebos -- administration & dosage
- Pneumococcal Vaccines -- administration & dosage
- Streptococcus pneumoniae -- immunology
- Streptolysins -- immunology
- Vaccination -- adverse effects
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.